Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 5, 2014, Pages 1373-1381

  Kutty, Preeta Krishnan ^a   Lawler, Jacqueline ^b   Rausch Phung, Elizabeth ^c   Ortega Sanchez, Ismael R ^a   Goodell, Stephen ^b   Schulte, Cynthia ^c   Pollock, Lynn ^c   Valure, Barbara ^b   Hudson, Jean ^b   Gallagher, Kathleen ^a   Blog, Debra ^c  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b Orange County Health Department   (United States)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

Economic; Highly vaccinated; Mumps; Outbreak; Vaccine

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MUMPS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; DISEASE SURVEILLANCE; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MUMPS; OUTCOME ASSESSMENT; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; TREATMENT RESPONSE; UNITED STATES; VACCINATION; CASE REPORT; DISEASE OUTBREAKS; ECONOMICS; HEALTH SURVEY; INFANT; PRESCHOOL CHILD; PROCEDURES; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HEALTH CARE COSTS; HUMANS; INFANT; MALE; MUMPS; MUMPS VACCINE; NEW YORK; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; VACCINATION; YOUNG ADULT;

EID: 84901392605     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.28389     Document Type: Article

References (53)

1. Centers for Disease Control (CDC). Measles prevention. MMWR Morb Mortal Wkly Rep 1989; 38(Suppl 9):1-18; PMID:2513473
2. Centers for Disease Control and Prevention (CDC). Notice to readers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for the control and elimination of mumps. MMWR Morb Mortal Wkly Rep 2006; 55:629-30; PMID:16761359
3. Vandermeulen C, Leroux-Roels G, Hoppenbrouwers K. Mumps outbreaks in highly vaccinated populations: What makes good even better? Hum Vaccin 2009; 5:494-6; PMID:19279405
4. Brockhoff HJ, Mollema L, Sonder GJ, Postema CA, van Binnendijk RS, Kohl RH, de Melker HE, Hahné SJ. Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine 2010; 28:2932-6; PMID:20188683; http://dx.doi.org/10.1016/j.vaccine.2010.02.020
5. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, Hunt K, Finley CG, Leschinsky DP, O'Keefe AL, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358:1580-9; PMID:18403766; http://dx.doi.org/10.1056/NEJMoa0706589
6. Whelan J, van Binnendijk R, Greenland K, Fanoy E, Khargi M, Yap K, Boot H, Veltman N, Swaan C, van der Bij A, et al. Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill 2010; 15: 19554; PMID:20460086
7. Bangor-Jones RD, Dowse GK, Giele CM, van Buynder PG, Hodge MM, Whitty MM. A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia. Med J Aust 2009; 191:398-401; PMID:19807634
8. Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B. Mumps outbreak in Israel's highly vaccinated society: are two doses enough? Epidemiol Infect 2012; 140:439-46; PMID:21554780; http://dx.doi.org/10.1017/ S095026881100063X
9. New York State Public Health Law. PHL 2164. [cited 2014 Feb 17]. Available from: http://www.health.ny.gov/regulations/public-health-law/.
10. Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, Cummings KP, Alleyne EO, High P, Lawler J, et al. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med 2012; 367:1704-13; PMID:23113481; http://dx.doi.org/10.1056/NEJMoa1202865
11. Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases: United States, 2000. MMWR Morb Mortal Wkly Rep 2002; 49:i-xxii, 1-100; PMID:12083162
12. Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases: United States, 2001. MMWR Morb Mortal Wkly Rep 2003; 50:i-xxiv, 1-108; PMID:12892074
13. Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases: United States, 2009. MMWR Morb Mortal Wkly Rep 2011; 58:1-100; PMID:21566560
14. Jajosky RA, Hall PA, Adams DA, Dawkins FJ, Sharp P, Anderson WJ, Aponte JJ, Jones GF, Nitschke DA, Worsham CA, et al.; Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases: United States, 2004. MMWR Morb Mortal Wkly Rep 2006; 53:1-79; PMID:16775578
15. McNabb SJ, Jajosky RA, Hall-Baker PA, Adams DA, Sharp P, Worshams C, Anderson WJ, Javier AJ, Jones GJ, Nitschke DA, et al.; Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases: United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 55:1-92; PMID:18354375
16. Centers for Disease Control and Prevention. Summary of Notifiable Diseases: United States, 2007. MMWR CDC Surveill Summ 2009; 56:1-94
17. Centers for Disease Control and Prevention. Summary of Notifiable Diseases: United States, 2008. MMWR CDC Surveill Summ 2010; 57:1-94
18. Centers for Disease Control and Prevention. National Immunization Survey (NIS). Vaccination Coverage Reported in the U.S. [cited 2014 Feb 17]. Available from: http://www.cdc.gov/vaccines/stats-surv/imzcoverage.htm.
19. Ogbuanu IU, Kutty PK, Hudson JM, et al. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak. Pediatrics 2012;130:e1567-74; PMID:23129075; http://dx.doi.org/10.1542/peds.2012-0177
20. Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: A historical perspective on unexpected elements. Vaccine 2009; 27:6186-95; PMID:19815120; http://dx.doi.org/10.1016/j.vaccine.2009.06.109
21. Mclean HQHC, Seward JF. The immunological basis for immunization series: Module 16: Mumps 2010. [cited 2014 Feb 17]. Available from: http://whqlibdoc. who.int/publications/2010/9789241500661-eng.pdf.
22. Deeks SL, Lim GH, Simpson MA, Gagné L, Gubbay J, Kristjanson E, Fung C, Crowcroft NS. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ 2011; 183:1014-20; PMID:21576295; http://dx.doi.org/10.1503/cmaj.101371
23. Cortese MM, Jordan HT, Curns AT, Quinlan PA, Ens KA, Denning PM, Dayan GH. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis 2008; 46:1172-80; PMID:18444852; http://dx.doi.org/10.1086/ 529141
24. Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis 2008; 197:950-6; PMID:18419470; http://dx.doi.org/10. 1086/528993
25. LeBaron CW, Forghani B, Beck C, Brown C, Bi D, Cossen C, Sullivan BJ. Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis 2009; 199:552-60; PMID:19113988; http://dx.doi.org/10.1086/596207
26. Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, Krohn T, Rowland J, Rubin S, Safranek TJ, Bellini WJ, et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis 2008; 197:1662-8; PMID:18419346; http://dx.doi.org/10.1086/588197
27. Kutty PK, McLean HQ, Lawler J, et al. Risk Factors for Transmission of Mumps in a Highly Vaccinated Population in Orange County, New York, 2009-2010. Pediatr Infect Dis J 2014; 33:121-5; http://dx.doi.org/10.1097/INF. 0000000000000020
28. Sullivan KM, Halpin TJ, Marks JS, Kim-Farley R. Effectiveness of mumps vaccine in a school outbreak. Am J Dis Child 1985; 139:909-12; PMID:4036925
29. Wharton M, Cochi SL, Hutcheson RH, Schaffner W. Mumps transmission in hospitals. Arch Intern Med 1990; 150:47-9; PMID:2297298; http://dx.doi.org/10. 1001/archinte.1990.00390130063006
30. Chaiken BP, Williams NM, Preblud SR, Parkin W, Altman R. The effect of a school entry law on mumps activity in a school district. JAMA 1987; 257:2455-8; PMID:3573244; http://dx.doi.org/10.1001/jama.1987.03390180073026
31. Hersh BS, Fine PE, Kent WK, Cochi SL, Kahn LH, Zell ER, Hays PL, Wood CL. Mumps outbreak in a highly vaccinated population. J Pediatr 1991; 119:187-93; PMID:1861205; http://dx.doi.org/10.1016/S0022-3476(05)80726-7
32. Briss PA, Fehrs LJ, Parker RA, Wright PF, Sannella EC, Hutcheson RH, Schaffner W. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis 1994; 169:77-82; PMID:8277201; http://dx.doi.org/10.1093/infdis/169. 1.77
33. Ruijs WL, Hautvast JL, Akkermans RP, Hulscher ME, van der Velden K. The role of schools in the spread of mumps among unvaccinated children: a retrospective cohort study. BMC Infect Dis 2011; 11:227; PMID:21864363; http://dx.doi.org/10.1186/1471-2334-11-227
34. Parker Fiebelkorn A, Rosen JB, Brown C, Zimmerman CM, Renshowitz H, D'Andrea C, Gallagher KM, Harpaz R, Zucker JR. Environmental factors potentially associated with mumps transmission in yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009-2010. Hum Vaccin Immunother 2013; 9:189-94; PMID:23442590; http://dx.doi.org/10.4161/hv.22415
35. Cheek JE, Baron R, Atlas H, Wilson DL, Crider RD Jr. Mumps outbreak in a highly vaccinated school population. Evidence for large-scale vaccination failure. Arch Pediatr Adolesc Med 1995; 149:774-8; PMID:7795768; http://dx.doi.org/10.1001/archpedi.1995.02170200064010
36. Rota JS, Rosen JB, Doll MK, McNall RJ, McGrew M, Williams N, Lopareva EN, Barskey AE, Punsalang A Jr., Rota PA, et al. Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009. Clin Vaccine Immunol 2013; 20:391-6; PMID:23324519; http://dx.doi.org/10.1128/CVI.00660-12
37. Abedi GR, Mutuc JD, Lawler J, Leroy ZC, Hudson JM, Blog DS, Schulte CR, Rausch-Phung E, Ogbuanu IU, Gallagher K, et al. Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak. Vaccine 2012; 30:7052-8; PMID:23041123; http://dx.doi.org/10.1016/j.vaccine.2012.09.053
38. Mahamud A, Fiebelkorn AP, Nelson G, Aguon A, McKenna J, Villarruel G, Gallagher K, Ortega-Sánchez IR. Economic impact of the 2009-2010 Guam mumps outbreak on the public health sector and affected families. Vaccine 2012; 30:6444-8; PMID:22902678; http://dx.doi.org/10.1016/j.vaccine.2012.08.001
39. Watson-Creed G, Saunders A, Scott J, Lowe L, Pettipas J, Hatchette TF. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. CMAJ 2006; 175:483-8; PMID:16940266; http://dx.doi.org/10. 1503/cmaj.060660
40. Janes A. Economic burden of the Nova Scotia mumps outbreak. In: Master of development economics. Halifax, Nova Scotia: Dalhousie University; 2010.
41. Ortega-Sanchez IR, Vijayaraghavan M, Barskey AE, Wallace GS. The economic burden of sixteen measles outbreaks on United States public health departments in 2011. Vaccine 2014; 32:1311-7; PMID:24135574; http://dx.doi.org/10.1016/j. vaccine.2013.10.012
42. Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D, Duks A, Griskevicius A, Johansen K, Bartha K, et al. Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations? Epidemiol Infect 2012; 12:1-16; PMID:22687578; http://dx.doi.org/10.1097/01.ede. 0000417196.70302.1d
43. World Health Organization. Mumps. [cited 2014 Feb 17]. Available from: http://www.who.int/immunization/monitoring-surveillance/burden/vpd/ surveillance-type/passive/mumps /en/index.html.
44. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62(RR-04):1-34; PMID:23760231
45. United States Census Bureau. 2010 Population Estimates. [cited 2014 Feb 17]. Available from: http://www.census.gov.
46. New York State Department of Health. Communicable Disease Reporting Requirements. [cited 2014 Feb 17]. Available from: http://www.health.ny.gov/ forms/instructions/doh-389-instructions.pdf.
47. Centers for Disease Conrol and Prevention. National Notifiable Diseases Surveillance System (NNDSS). Accessible at http://wwwn.cdc.gov/nndss/default. aspx. Date accessed: 2/17/2014.
48. Council of State and Territorial Epidemiologists. Revision of the Surveillance Case Definition for Mumps. 2009. [cited 2014 Feb 17]. Available from: http://c.ymcdn.com/sites/www.cste.org/resource/resmgr/PS/09-ID-50.pdf.
49. Diamedix Corporation. SCIMEDIX Indirect Fluorescence Assay (IFA) Mumps. [cited 2014 Feb 17]. Available from: http://www.diamedix.com/en/technical- information/package-inserts/infectiousifa/Mumps-IgG-S-I-MUV01G.pdf.
50. Boddicker JD, Rota PA, Kreman T, Wangeman A, Lowe L, Hummel KB, Thompson R, Bellini WJ, Pentella M, Desjardin LE. Real-time reverse transcription-PCR assay for detection of mumps virus RNA in clinical specimens. J Clin Microbiol 2007; 45:2902-8; PMID:17652480; http://dx.doi.org/10.1128/JCM.00614-07
51. Centers for Disease Control and Prevention. Realtime (TaqMan®) RT-PCR assay for the detection of mumps virus RNA in clinical samples. [cited 2014 Feb 17]. Available from: http://www.cdc.gov/mumps/downloads/lab-rt-pcr-assay- detect.doc.
52. Rota JS, Turner JC, Yost-Daljev MK, Freeman M, Toney DM, Meisel E, Williams N, Sowers SB, Lowe L, Rota PA, et al. Investigation of a mumps outbreak among university students with two measles-mumpsrubella (MMR) vaccinations, Virginia, September-December 2006. J Med Virol 2009; 81:1819-25; PMID:19697404; http://dx.doi.org/10.1002/jmv.21557
53. Jin L, Rima B, Brown D, Orvell C, Tecle T, Afzal M, Uchida K, Nakayama T, Song JW, Kang C, et al. Proposal for genetic characterisation of wildtype mumps strains: preliminary standardisation of the nomenclature. Arch Virol 2005; 150:1903-9; PMID:15959834; http://dx.doi.org/10.1007/s00705-005-0563-4